Approaches to Optimal Dosing of Vitamin K AntagonistsWITT, Daniel M.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 7, pp 667-672, issn 0094-6176, 6 p.Article

A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional careWITT, Daniel M; HUMPHRIES, Tammy L.Journal of thrombosis and thrombolysis. 2003, Vol 15, Num 2, pp 113-118, issn 0929-5305, 6 p.Article

Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-mL (pediatric) tubesJUNG CHUANG; SADLER, Melanie A; WITT, Daniel M et al.Chest. 2004, Vol 126, Num 4, pp 1262-1266, issn 0012-3692, 5 p.Article

Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapyWITT, Daniel M; SADLER, Melanie A; SHANAHAN, Roberta L et al.Chest. 2005, Vol 127, Num 5, pp 1515-1522, issn 0012-3692, 8 p.Article

Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organizationTILLMAN, Donald J; CHARLAND, Scott L; WITT, Daniel M et al.Archives of internal medicine (1960). 2000, Vol 160, Num 19, pp 2926-2932, issn 0003-9926Article

Outcomes Associated With Combined Antiplatelet and Anticoagulant therapyJOHNSON, Samuel G; ROGERS, Kristina; DELATE, Thomas et al.Chest. 2008, Vol 133, Num 4, pp 948-954, issn 0012-3692, 7 p.Article

Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract BleedingWITT, Daniel M; DELATE, Thomas; GARCIA, David A et al.Archives of internal medicine (1960). 2012, Vol 172, Num 19, pp 1484-1491, issn 0003-9926, 8 p.Article

Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancyCLARK, Nathan P; DELATE, Thomas; CLEARY, Steven J et al.Thrombosis research. 2010, Vol 125, Num 5, pp 402-405, issn 0049-3848, 4 p.Article

Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion programWITT, Daniel M; TILLMAN, Donald; EVANS, Christy M et al.Pharmacotherapy. 2003, Vol 23, Num 3, pp 360-368, issn 0277-0008, 9 p.Article

Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management serviceJOHNSON, Samuel G; WITT, Daniel M; EDDY, Todd R et al.Chest. 2007, Vol 131, Num 5, pp 1500-1507, issn 0012-3692, 8 p.Article

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulationPATEL, Rachana J; WITT, Daniel M; SASEEN, Joseph J et al.Pharmacotherapy. 2000, Vol 20, Num 10, pp 1159-1166, issn 0277-0008Conference Paper

Evolution, Current Structure, and Role of a Primary Care Clinical Pharmacy Service in an Integrated Managed Care OrganizationHEILMANN, Rachel M. F; CAMPBELL, Stephanie M; KRONER, Beverly A et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 1, pp 124-131, issn 1060-0280, 8 p.Article

A Randomized Controlled Trial of Empiric Warfarin Dose Reduction with the Initiation of Doxycycline TherapyDOWD, Mary Beth; KIPPES, Kellie A; WITT, Daniel M et al.Thrombosis research. 2012, Vol 130, Num 2, pp 152-156, issn 0049-3848, 5 p.Article

Pilot Study of a Novel Patient Self-Management Program for Warfarin Therapy Using Venipuncture-Acquired International Normalized Ratio MonitoringSIMMONS, Brandon J; JENNER, Kathleen M; DELATE, Thomas et al.Pharmacotherapy. 2012, Vol 32, Num 12, pp 1078-1084, issn 0277-0008, 7 p.Article